Post-traumatic stress disorder is a common, chronic, and often disabling mental illness.
Selective serotonin reuptake inhibitors are the usual first-line treatment for post-traumatic …

Objective: Cost-effectiveness of treatment for posttraumatic stress disorder (PTSD) may
depend on type of treatment (eg, pharmacotherapy vs psychotherapy) and patient choice of …

Exposure of the general population to a 1: 4 lifetime risk of disabling anxiety has inspired
generations of fundamental and clinical psychopharmacologists, from the era of the earliest …

There is a good amount of evidence that exposure therapy is an effective treatment for
posttraumatic stress disorder (PTSD). Notwithstanding its efficacy, there is room for …

The terrorist attacks of September 11, 2001, and the constant threat of imminent terrorist
activity have brought into the forefront the urgent need to prepare for the consequences of …

OBJECTIVE: This article describes current approaches to the pharmacologic treatment of
posttraumatic stress disorder (PTSD) and reviews the classes of pharmacologic agents used …

Objective: The revised Department of Veterans Affairs (VA) and Department of Defense
Clinical Practice Guideline for Management of Post-Traumatic Stress recommends against …

Background Combined treatment with a selective serotonin reuptake inhibitor (SSRI) plus
mirtazapine has shown superior efficacy in some studies of depression, but has not been …

Exposure to extreme stress can exert profound and lasting changes on human cognition,
emotion, and behavior. Historically, children's responses to stress and trauma have been …

This article reviews pharmacologic treatment options for posttraumatic stress disorder
(PTSD), focusing on goals of pharmacotherapy and the clinical trial evidence for drug …